SciSparc Ltd

SPRC

Company Profile

  • Business description

    SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

  • Contact

    20 Raul Wallenberg Street
    Tower A, 2nd Floor
    Tel Aviv6971916
    ISR

    T: +972 37175777

    https://www.scisparc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    3

Stocks News & Analysis

stocks

Avoid this overvalued ASX lithium producer

Why the market may be overpricing future earnings for this lithium producer.
stocks

Morningstar's verdict on SpaceX

Mark and Shani run through the business and what our analysts think about the IPO.
stocks

More problems for WiseTech

Our view of police investigation into chairman Richard White.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,012.6010.700.12%
CAC 408,352.8612.150.15%
DAX 4024,649.39244.19-0.98%
Dow JONES (US)51,666.8445.87-0.09%
FTSE 10010,418.7610.09-0.10%
HKSE23,412.1875.900.33%
NASDAQ25,587.04579.56-2.21%
Nikkei 22569,174.97613.41-0.88%
NZX 50 Index13,400.6635.11-0.26%
S&P 5007,365.46107.33-1.44%
S&P/ASX 2008,808.407.000.08%
SSE Composite Index4,110.814.560.11%

Market Movers